Skip to main content

PharmaCyte Biotech, Inc.

PMCB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001157075

No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in PharmaCyte Biotech, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
32
0 vs. Q1 2024
Shares held
1.03M
+54.1K (+5.5%) vs. Q1 2024
Total value
$2.02M
−$296.0K (−12.8%) vs. Q1 2024
New holders
3
10 more added
Sold out
3
8 more reduced

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 32 institutions
Q1 2021: 5 institutionsQ2 2021: 5 institutionsQ3 2021: 24 institutionsQ4 2021: 30 institutionsQ1 2022: 28 institutionsQ2 2022: 35 institutionsQ3 2022: 33 institutionsQ4 2022: 34 institutionsQ1 2023: 33 institutionsQ2 2023: 32 institutionsQ3 2023: 34 institutionsQ4 2023: 36 institutionsQ1 2024: 33 institutionsQ2 2024: 32 institutionsQ3 2024: 29 institutionsQ4 2024: 23 institutionsQ1 2025: 26 institutionsQ2 2025: 25 institutionsQ3 2025: 25 institutionsQ4 2025: 30 institutionsQ1 2026: 36 institutionsQ2 2026: 32 institutions
Value heldQ2 2024: $2.02M
Q1 2021: $8.68KQ2 2021: $5.43KQ3 2021: $4.42MQ4 2021: $8.68MQ1 2022: $8.83MQ2 2022: $8.79MQ3 2022: $12.0MQ4 2022: $9.93MQ1 2023: $10.2MQ2 2023: $3.47MQ3 2023: $2.40MQ4 2023: $2.35MQ1 2024: $2.32MQ2 2024: $2.02MQ3 2024: $1.58MQ4 2024: $934.3KQ1 2025: $709.9KQ2 2025: $632.1KQ3 2025: $419.9KQ4 2025: $712.0KQ1 2026: $643.2KQ2 2026: $586.2K
Institutions holding PMCB and their total value by quarter
QuarterHoldersValue
Q2 202632$586.2K
Q1 202636$643.2K
Q4 202530$712.0K
Q3 202525$419.9K
Q2 202525$632.1K
Q1 202526$709.9K
Q4 202423$934.3K
Q3 202429$1.58M
Q2 202432$2.02M
Q1 202433$2.32M
Q4 202336$2.35M
Q3 202334$2.40M
Q2 202332$3.47M
Q1 202333$10.2M
Q4 202234$9.93M
Q3 202233$12.0M
Q2 202235$8.79M
Q1 202228$8.83M
Q4 202130$8.68M
Q3 202124$4.42M
Q2 20215$5.43K
Q1 20215$8.68K

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q1 2024.

Institutions holding PMCB in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
K2 Principal Fund, L.P.327,503$641.9K0.14%00.0%Unchanged
Vanguard Group Inc192,387$377.1K0.00%+17,785+10.2%Added
Geode Capital Management, LLC176,605$346.2K0.00%−23,676−11.8%Reduced
Equitec Proprietary Markets, LLC82,727$162.1K1.23%00.0%Unchanged
Susquehanna International Group, LLP54,834$107.5K0.00%+13,646+33.1%Added
Renaissance Technologies LLC48,500$95.1K0.00%+4,700+10.7%Added
Two Sigma Securities, LLC27,750$54.4K0.00%+27,750New
UBS Group AG27,575$54.0K0.00%+27,566+306,288.9%Added
Dimensional Fund Advisors LP25,596$50.2K0.00%+1,033+4.2%Added
Schonfeld Strategic Advisors LLC23,700$46.5K0.00%+200+0.9%Added
Northern Trust Corp19,208$37.6K0.00%−21−0.1%Reduced
BlackRock Inc.13,346$26.2K0.00%−7,758−36.8%Reduced
Tower Research Capital LLC (TRC)7,384$14.5K0.00%+4,155+128.7%Added
Acadian Asset Management LLC2,851$5.00K0.00%−738−20.6%Reduced
Aspire Private Capital, LLC800$1.57K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.513$1.00K0.00%−1,254−71.0%Reduced
Kelly Financial Services LLC234$4590.00%00.0%Unchanged
Bank of America Corp152$2980.00%+98+181.5%Added
Planning Capital Management Corp100$1960.00%+100New
Redwood Wealth Management Group, LLC69$1350.00%+69New
Anchor Investment Management, LLC27$530.00%00.0%Unchanged
JPMorgan Chase & Co19$370.00%+1+5.6%Added
Sachetta, LLC14$280.00%00.0%Unchanged
BFSG, LLC5$100.00%−2−28.6%Reduced
Morgan Stanley3$70.00%00.0%Unchanged
GWM Advisors LLC2$40.00%−1−33.3%Reduced
Caldwell Sutter Capital, Inc.2$40.00%00.0%Unchanged
Carolina Wealth Advisors, LLC2$40.00%00.0%Unchanged
CWM, LLC1$00.00%−953−99.9%Reduced
Covestor Ltd226$00.00%00.0%Unchanged
Huntington National Bank1$00.00%00.0%Unchanged
Royal Bank of Canada261$00.00%+105+67.3%Added
Citadel Advisors LLC0$00.00%−8,561−100.0%Sold out
Wells Fargo & Company0$00.00%−55−100.0%Sold out
Private Wealth Management Group, LLC0$00.00%−42−100.0%Sold out
Highlander Capital Management, LLC––––Not filed